"New Protein Target Offers Hope in Slowing Alzheimer's Progression"
Researchers from the Icahn School of Medicine at Mount Sinai have discovered that targeting the protein plexin-B1 in the brain may help clear beta-amyloid plaques, a hallmark of Alzheimer's disease. This early-stage research suggests that modifying cellular interactions involving plexin-B1 and reactive astrocytes could reduce neurotoxicity and neuroinflammation, potentially leading to new treatment options. However, experts caution that these findings are preliminary and need further validation in human studies.
